BioCentury
ARTICLE | Distillery Therapeutics

Gastrointestinal

March 21, 2017 3:21 PM UTC

In vitro and mouse studies identified a chlorobenzamide-based inhibitor of bromodomain 1 of BET bromodomain proteins that could help treat colitis. Structure-based design, chemical synthesis and in vi...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article